Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
special când componenta de sedare nu este necesară
Yüklə 4,39 Mb.
|
| special când componenta de sedare nu este necesară.
Tratamentul bulimiei nervoase. Tratamentul tulburărilor obsesiv-compulsive. Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ N06AB03 FLUOXETINUM CAPS. 20 mg FLUOXETINE 20 mg 20 mg DR. REDDY'S LABORATORIES FLUOXIN 20 mg VIM SPECTRUM SRL FLURAN 20 mg RANBAXY U.K. LIMITED MAGRILAN 20 mg 20 mg MEDOCHEMIE LTD. N06AB03 FLUOXETINUM COMPR. DISP. 20 mg PROZAC 20 mg 20 mg ELI LILLY SA ________________________________________________________________________________
| 132 |N06AB04| CITALOPRAMUM** | Protocol: N008F | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ N06AB04 CITALOPRAMUM COMPR. FILM. 10 mg CITALORAN 10 mg 10 mg RANBAXY UK LIMITED LINISAN 10 mg 10 mg GEDEON RICHTER ROMANIA S.A.
CITALORAN 20 mg 20 mg RANBAXY UK LIMITED LINISAN 20 mg 20 mg GEDEON RICHTER ROMANIA S.A.
CITALORAN 40 mg 40 mg RANBAXY UK LIMITED LINISAN 40 mg 40 mg GEDEON RICHTER ROMANIA S.A. ________________________________________________________________________________ ______________________________________________________________________________ | 133 |N06AB05| PAROXETINUM* | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|